55 related articles for article (PubMed ID: 22417659)
41. Mucociliary clearance in cystic fibrosis.
Robinson M; Bye PT
Pediatr Pulmonol; 2002 Apr; 33(4):293-306. PubMed ID: 11921459
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological approaches to discovery and development of new mucolytic agents.
King M; Rubin BK
Adv Drug Deliv Rev; 2002 Dec; 54(11):1475-90. PubMed ID: 12458156
[TBL] [Abstract][Full Text] [Related]
43. Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function.
Reeves EP; McCarthy C; McElvaney OJ; Vijayan MS; White MM; Dunlea DM; Pohl K; Lacey N; McElvaney NG
World J Crit Care Med; 2015 Aug; 4(3):179-91. PubMed ID: 26261770
[TBL] [Abstract][Full Text] [Related]
44. Airway-clearance therapy guidelines and implementation.
Lester MK; Flume PA
Respir Care; 2009 Jun; 54(6):733-50; discussion 751-3. PubMed ID: 19467161
[TBL] [Abstract][Full Text] [Related]
45. Methods Used to Evaluate the Immediate Effects of Airway Clearance Techniques in Adults with Cystic Fibrosis: A Systematic Review and Meta-Analysis.
Chapman N; Watson K; Hatton T; Cavalheri V; Wood J; Gucciardi DF; Smith EF; Hill K
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830562
[TBL] [Abstract][Full Text] [Related]
46. Secretion properties, clearance, and therapy in airway disease.
Rubin BK
Transl Respir Med; 2014; 2():6. PubMed ID: 25505698
[TBL] [Abstract][Full Text] [Related]
47. Airway Clearance Therapy in Cystic Fibrosis Patients Insights from a Clinician Providing Cystic Fibrosis Care.
Chaudary N; Balasa G
Int J Gen Med; 2021; 14():2513-2521. PubMed ID: 34163219
[TBL] [Abstract][Full Text] [Related]
48. The Mucus Barrier to Inhaled Gene Therapy.
Duncan GA; Jung J; Hanes J; Suk JS
Mol Ther; 2016 Dec; 24(12):2043-2053. PubMed ID: 27646604
[TBL] [Abstract][Full Text] [Related]
49. Airway-Clearance Techniques in Children and Adolescents with Chronic Suppurative Lung Disease and Bronchiectasis.
Lee AL; Button BM; Tannenbaum EL
Front Pediatr; 2017; 5():2. PubMed ID: 28168184
[TBL] [Abstract][Full Text] [Related]
50. CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis.
Aquino ES; Shimura F; Santos AS; Goto DM; Coelho CC; de Fuccio MB; Saldiva PH; Lorenzi-Filho G; Rubin BK; Nakagawa NK
Respir Care; 2012 Nov; 57(11):1914-9. PubMed ID: 22417659
[TBL] [Abstract][Full Text] [Related]
51. Mucus structure and properties in cystic fibrosis.
Rubin BK
Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic aerosols and airway secretions.
Rubin BK
J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
[TBL] [Abstract][Full Text] [Related]
53. Noninvasive clearance of airway secretions.
Hardy KA; Anderson BD
Respir Care Clin N Am; 1996 Jun; 2(2):323-45. PubMed ID: 9390886
[TBL] [Abstract][Full Text] [Related]
54. Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: an overview of five Cochrane systematic reviews.
Bradley JM; Moran FM; Elborn JS
Respir Med; 2006 Feb; 100(2):191-201. PubMed ID: 16412951
[TBL] [Abstract][Full Text] [Related]
55. The use of pulmonary clearance medications in the acutely ill patient.
Papacostas MF; Luckett P; Hupp S
Expert Rev Respir Med; 2017 Oct; 11(10):815-826. PubMed ID: 28780895
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
